Results 111 to 120 of about 13,691 (157)

Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system. [PDF]

Medicine (Baltimore)
Huang X, Chen Y, Li S, Wen Y, Liu H, Cao G.   +5 more
europepmc   +1 more source

Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies. [PDF]

Front Pharmacol
Torres de Souza G, Williams G, Vicente Silva CC, Chiovatto CB, Epstein GK, Vila-Vecilla L, Russo V.   +6 more
europepmc   +1 more source

Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of Androgenetic Alopecia.

J Cosmet Dermatol
Li G, Geng J, Liang J, Gao J, Ma L, Zhang Y, Huang Y, Zhang B, Zhang Y, Shangguan J, Liu S.   +10 more
europepmc   +1 more source

The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives. [PDF]

Biology (Basel)
Gupta AK, Dennis DJ, Economopoulos V, Piguet V.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Finasteride

Drugs, 2012
Karen J Mcclellan, K J Mcclellan, Markham Anthony   +2 more
exaly   +4 more sources

Finasteride

Expert Opinion on Drug Metabolism & Toxicology, 2010
Prostate cancer is the most common non-cutaneous malignancy in males in the US. Prostate cancer chemoprevention entails the use of agents which retard or inhibit the progression to invasive disease. Chemoprevention is an attractive option for patients with prostate cancer given the hormonally responsive nature of cancer, long latency period and high ...
Uzair B, Chaudhary, Jeffrey S, Turner
openaire   +3 more sources

Finasteride

Reactions Weekly, 2021
  +6 more sources

Finasteride

Reactions Weekly
J. Russell May, Emily Strickland
  +6 more sources

Finasteride

Reactions Weekly, 2022
openaire   +2 more sources